From VAXOPEDIA <[email protected]>
Subject The Novavax COVID Vaccine Has Been Approved
Date May 19, 2025 2:03 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Post : The Novavax COVID Vaccine Has Been Approved
URL : [link removed]
Posted : May 19, 2025 at 8:01 am
Author : Vincent Iannelli, MD
Tags : ACIP, covid vaccines, high risk conditions, new COVID vaccines, non-mRNA vaccine, Nuvaxovid, severe COVID
Categories : COVID-19

The FDA has approved Novavax's Nuvaxovid, a non-mRNA COVID vaccine aimed at adults 65 and high-risk individuals aged 12-64. Although the approval is limited, many people qualify due to underlying conditions. Nuvaxovid offers an effective alternative, with simpler storage and fewer side effects compared to other vaccines.

Continue reading ( [link removed] )

--


Manage Subscriptions
[link removed]

Unsubscribe:
[link removed]
Screenshot of the email generated on import

Message Analysis

  • Sender: n/a
  • Political Party: n/a
  • Country: n/a
  • State/Locality: n/a
  • Office: n/a
  • Email Providers:
    • Wordpress.com